AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript [The Motley Fool]
Last acelrx pharmaceuticals, inc earnings: 3/16 07:35 am
Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations
AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript -- The Motley Fool AcelRx Pharmaceuticals Inc (ACRX) Q 09 Earnings Call Transcript ACRX earnings call for the period ending June 0, 09. MFTranscribers Image source: The Motley Fool. NASDAQ:ACRX Aug , 09 :00 p.m. ET Contents: : Operator Welcome to the AcelRx Second Quarter 09 Conference Call. This call is being webcast live on the Events page of the Investors section of AcelRx's website at acelrx.com. This call is the property of AcelRx and any recording, reproduction, or transmission of this call without the express written consent of AcelRx is strictly prohibited. [Operator Instructions] You may listen to a webcast replay of this call by going to the Investors section of Acel's website. I would like to now turn the call over to Raffi Asadorian, AcelRx's Chief Financial Officer. Thank you. And thank you for joining us this afternoon. Earlier today, we reported our second quarter 09 financial results and provided an
[Read more]
| Impact snapshot | Event time: | ACRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ACRX alerts
ACRX alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRX alerts
High impacting AcelRx Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics
ACRX
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AcelRx Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ACRXGlobeNewswire
- SHAREHOLDER ALERT: Robbins LLP Announces that AcelRX Pharmaceuticals, Inc. (ACRX) is Being Sued for Misleading ShareholdersBusiness Wire
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) InvestorsBusiness Wire
- ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXPR Newswire
- SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire
- More
ACRX
SEC Filings
- 5/17/21 - Form 10-Q
- 5/17/21 - Form 8-K
- 4/27/21 - Form 8-K
- ACRX's page on the SEC website
- More